SCHEMBL7329075

SCHEMBL7329075

Cc1cc(-c2ccccc2)[nH]c1C=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.51
NPC1 O15118 3/20 0.51
KDM4E B2RXH2 9/20 0.49
GAA P10253 4/20 0.49
HPGD P15428 6/20 0.46
ALDH1A1 P00352 5/20 0.46
HSD17B10 Q99714 3/20 0.45
LMNA P02545 2/20 0.45
TP53 P04637 2/20 0.45
MAPT P10636 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CYP3A4 P08684 2/20 0.44
CYP2C9 P11712 2/20 0.44
POLB P06746 1/20 0.44
TNKS2 Q9H2K2 1/20 0.44
BRD4 O60885 1/20 0.44
CYP2C19 P33261 2/20 0.43
CTSV O60911 1/20 0.43
TUBB4A P04350 1/20 0.43
TUBB P07437 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL185969 0.83 NPC1 (0.53) RAB9ANPC1KDM4EHPGDALDH1A1
SCHEMBL9766805 0.82 GRIA1 (0.38) KDM4EGAAHPGDALDH1A1LMNA
SCHEMBL7328512 0.74 RAB9A (0.66) RAB9ANPC1KDM4EGAAHPGD
SCHEMBL28442582 0.74 ALDH1A1 (0.45) RAB9ANPC1KDM4EGAAHPGD
SCHEMBL21757291 0.74 BRD4 (0.55) RAB9ANPC1KDM4EGAAHPGD
SCHEMBL21746 0.73
SCHEMBL26584500 0.72 NPC1 (0.53) RAB9ANPC1KDM4EGAAHPGD
SCHEMBL18787987 0.71 NPC1 (0.52) RAB9ANPC1KDM4EGAAHPGD
SCHEMBL9908159 0.70 RAB9A (0.40) RAB9ANPC1KDM4EGAAHPGD
SCHEMBL3417874 0.70 NPC1 (0.40) RAB9ANPC1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5545645-A Heterocyclic derivatives in the treatment of ischaemia and related diseases SYNTEX PHARMACEUTICALS, LIMITED (GB) 1996-08-13 US disclosed
EP-0693062-A1 HETEROCYCLIC DERIVATIVES IN THE TREATMENT OF ISCHAEMIA AND RELATED DISEASES SYNTEX PHARMACEUTICALS LTD. (GB) 1996-01-24 EP disclosed
US-5428037-A Piperazine derivatives; calcium and sodium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1995-06-27 US disclosed
WO-1994024116-A1 HETEROCYCLIC DERIVATIVES IN THE TREATMENT OF ISCHAEMIA AND RELATED DISEASES SYNTEX PHARMACEUTICALS LIMITED (GB) 1994-10-27 WO disclosed